Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species

Feng Chen, Scott A Barman, Yanfang Yu, Steven Haigh, Yusi Wang, Huijuan Dou, Zsolt Bagi, Weihong Han, Yunchao Su, David J Fulton

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Changes in the expression and function of caveolin-1 (Cav-1) have been proposed as a pathogenic mechanism underlying many cardiovascular diseases. Cav-1 binds to and regulates the activity of numerous signaling proteins via interactions with its scaffolding domain. In endothelial cells, Cav-1 has been shown to reduce reactive oxygen species (ROS) production, but whether Cav-1 regulates the activity of NADPH oxidases (Noxes), a major source of cellular ROS, has not yet been shown. Herein, we show that Cav-1 is primarily expressed in the endothelium and adventitia of pulmonary arteries (PAs) and that Cav-1 expression is reduced in isolated PAs from multiple models of pulmonary artery hypertension (PH). Reduced Cav-1 expression correlates with increased ROS production in the adventitia of hypertensive PA. In vitro experiments revealed a significant ability of Cav-1 and its scaffolding domain to inhibit Nox1-5 activity and it was also found that Cav-1 binds to Nox5 and Nox2 but not Nox4. In addition to posttranslational actions, in primary cells, Cav-1 represses the mRNA and protein expression of Nox2 and Nox4 through inhibition of the NF-κB pathway. Last, in a mouse hypoxia model, the genetic ablation of Cav-1 increased the expression of Nox2 and Nox4 and exacerbated PH. Together, these results suggest that Cav-1 is a negative regulator of Nox function via two distinct mechanisms, acutely through direct binding and chronically through alteration of expression levels. Accordingly, the loss of Cav-1 expression in cardiovascular diseases such as PH may account for the increased Nox activity and greater production of ROS.

Original languageEnglish (US)
Pages (from-to)201-213
Number of pages13
JournalFree Radical Biology and Medicine
Volume73
DOIs
StatePublished - Jan 1 2014

Fingerprint

Caveolin 1
NADPH Oxidase
Reactive Oxygen Species
Pulmonary Artery
Pulmonary Hypertension
Adventitia
Cardiovascular Diseases
Genetic Models
Endothelial cells
Ablation
Endothelium

Keywords

  • Caveolin-1
  • Free radicals
  • NADPH oxidase
  • Pulmonary hypertension
  • Reactive oxygen species

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species. / Chen, Feng; Barman, Scott A; Yu, Yanfang; Haigh, Steven; Wang, Yusi; Dou, Huijuan; Bagi, Zsolt; Han, Weihong; Su, Yunchao; Fulton, David J.

In: Free Radical Biology and Medicine, Vol. 73, 01.01.2014, p. 201-213.

Research output: Contribution to journalArticle

Chen, Feng ; Barman, Scott A ; Yu, Yanfang ; Haigh, Steven ; Wang, Yusi ; Dou, Huijuan ; Bagi, Zsolt ; Han, Weihong ; Su, Yunchao ; Fulton, David J. / Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species. In: Free Radical Biology and Medicine. 2014 ; Vol. 73. pp. 201-213.
@article{4989cb0a53ef4e5987faca3a109284ff,
title = "Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species",
abstract = "Changes in the expression and function of caveolin-1 (Cav-1) have been proposed as a pathogenic mechanism underlying many cardiovascular diseases. Cav-1 binds to and regulates the activity of numerous signaling proteins via interactions with its scaffolding domain. In endothelial cells, Cav-1 has been shown to reduce reactive oxygen species (ROS) production, but whether Cav-1 regulates the activity of NADPH oxidases (Noxes), a major source of cellular ROS, has not yet been shown. Herein, we show that Cav-1 is primarily expressed in the endothelium and adventitia of pulmonary arteries (PAs) and that Cav-1 expression is reduced in isolated PAs from multiple models of pulmonary artery hypertension (PH). Reduced Cav-1 expression correlates with increased ROS production in the adventitia of hypertensive PA. In vitro experiments revealed a significant ability of Cav-1 and its scaffolding domain to inhibit Nox1-5 activity and it was also found that Cav-1 binds to Nox5 and Nox2 but not Nox4. In addition to posttranslational actions, in primary cells, Cav-1 represses the mRNA and protein expression of Nox2 and Nox4 through inhibition of the NF-κB pathway. Last, in a mouse hypoxia model, the genetic ablation of Cav-1 increased the expression of Nox2 and Nox4 and exacerbated PH. Together, these results suggest that Cav-1 is a negative regulator of Nox function via two distinct mechanisms, acutely through direct binding and chronically through alteration of expression levels. Accordingly, the loss of Cav-1 expression in cardiovascular diseases such as PH may account for the increased Nox activity and greater production of ROS.",
keywords = "Caveolin-1, Free radicals, NADPH oxidase, Pulmonary hypertension, Reactive oxygen species",
author = "Feng Chen and Barman, {Scott A} and Yanfang Yu and Steven Haigh and Yusi Wang and Huijuan Dou and Zsolt Bagi and Weihong Han and Yunchao Su and Fulton, {David J}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.freeradbiomed.2014.04.029",
language = "English (US)",
volume = "73",
pages = "201--213",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species

AU - Chen, Feng

AU - Barman, Scott A

AU - Yu, Yanfang

AU - Haigh, Steven

AU - Wang, Yusi

AU - Dou, Huijuan

AU - Bagi, Zsolt

AU - Han, Weihong

AU - Su, Yunchao

AU - Fulton, David J

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Changes in the expression and function of caveolin-1 (Cav-1) have been proposed as a pathogenic mechanism underlying many cardiovascular diseases. Cav-1 binds to and regulates the activity of numerous signaling proteins via interactions with its scaffolding domain. In endothelial cells, Cav-1 has been shown to reduce reactive oxygen species (ROS) production, but whether Cav-1 regulates the activity of NADPH oxidases (Noxes), a major source of cellular ROS, has not yet been shown. Herein, we show that Cav-1 is primarily expressed in the endothelium and adventitia of pulmonary arteries (PAs) and that Cav-1 expression is reduced in isolated PAs from multiple models of pulmonary artery hypertension (PH). Reduced Cav-1 expression correlates with increased ROS production in the adventitia of hypertensive PA. In vitro experiments revealed a significant ability of Cav-1 and its scaffolding domain to inhibit Nox1-5 activity and it was also found that Cav-1 binds to Nox5 and Nox2 but not Nox4. In addition to posttranslational actions, in primary cells, Cav-1 represses the mRNA and protein expression of Nox2 and Nox4 through inhibition of the NF-κB pathway. Last, in a mouse hypoxia model, the genetic ablation of Cav-1 increased the expression of Nox2 and Nox4 and exacerbated PH. Together, these results suggest that Cav-1 is a negative regulator of Nox function via two distinct mechanisms, acutely through direct binding and chronically through alteration of expression levels. Accordingly, the loss of Cav-1 expression in cardiovascular diseases such as PH may account for the increased Nox activity and greater production of ROS.

AB - Changes in the expression and function of caveolin-1 (Cav-1) have been proposed as a pathogenic mechanism underlying many cardiovascular diseases. Cav-1 binds to and regulates the activity of numerous signaling proteins via interactions with its scaffolding domain. In endothelial cells, Cav-1 has been shown to reduce reactive oxygen species (ROS) production, but whether Cav-1 regulates the activity of NADPH oxidases (Noxes), a major source of cellular ROS, has not yet been shown. Herein, we show that Cav-1 is primarily expressed in the endothelium and adventitia of pulmonary arteries (PAs) and that Cav-1 expression is reduced in isolated PAs from multiple models of pulmonary artery hypertension (PH). Reduced Cav-1 expression correlates with increased ROS production in the adventitia of hypertensive PA. In vitro experiments revealed a significant ability of Cav-1 and its scaffolding domain to inhibit Nox1-5 activity and it was also found that Cav-1 binds to Nox5 and Nox2 but not Nox4. In addition to posttranslational actions, in primary cells, Cav-1 represses the mRNA and protein expression of Nox2 and Nox4 through inhibition of the NF-κB pathway. Last, in a mouse hypoxia model, the genetic ablation of Cav-1 increased the expression of Nox2 and Nox4 and exacerbated PH. Together, these results suggest that Cav-1 is a negative regulator of Nox function via two distinct mechanisms, acutely through direct binding and chronically through alteration of expression levels. Accordingly, the loss of Cav-1 expression in cardiovascular diseases such as PH may account for the increased Nox activity and greater production of ROS.

KW - Caveolin-1

KW - Free radicals

KW - NADPH oxidase

KW - Pulmonary hypertension

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84902248613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902248613&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2014.04.029

DO - 10.1016/j.freeradbiomed.2014.04.029

M3 - Article

VL - 73

SP - 201

EP - 213

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -